| Machine learning algorithms for outcome prediction in (chemo) radiotherapy: An empirical comparison of classifiers TM Deist, FJWM Dankers, G Valdes, R Wijsman, IC Hsu, C Oberije, ... Medical physics 45 (7), 3449-3459, 2018 | 294 | 2018 |
| Multivariable normal-tissue complication modeling of acute esophageal toxicity in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo … R Wijsman, F Dankers, EGC Troost, AL Hoffmann, ... Radiotherapy and Oncology 117 (1), 49-54, 2015 | 83* | 2015 |
| Evaluation of interplay and organ motion effects by means of 4D dose reconstruction and accumulation A Meijers, AC Knopf, APG Crijns, JF Ubbels, AGH Niezink, JA Langendijk, ... Radiotherapy and Oncology 150, 268-274, 2020 | 65 | 2020 |
| Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival EJ Bantema-Joppe, HP van Der Laan, GH de Bock, R Wijsman, ... Radiotherapy and oncology 100 (2), 215-220, 2011 | 48 | 2011 |
| Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-) radiotherapy using IMRT or VMAT R Wijsman, F Dankers, EGC Troost, AL Hoffmann, EHFM van der Heijden, ... Radiotherapy and Oncology 122 (2), 295-299, 2017 | 47 | 2017 |
| Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography R Wijsman, J Kaanders, WJG Oyen, J Bussink Quarterly Journal of Nuclear Medicine and Molecular Imaging 57 (3), 244-256, 2013 | 38 | 2013 |
| Towards the clinical implementation of intensity-modulated proton therapy for thoracic indications with moderate motion: Robust optimised plan evaluation by means of patient … CO Ribeiro, S Visser, EW Korevaar, NM Sijtsema, RM Anakotta, M Dieters, ... Radiotherapy and Oncology 157, 210-218, 2021 | 36 | 2021 |
| Clinical suitability of deep learning based synthetic CTs for adaptive proton therapy of lung cancer A Thummerer, C Seller Oria, P Zaffino, A Meijers, G Guterres Marmitt, ... Medical physics 48 (12), 7673-7684, 2021 | 28 | 2021 |
| Deep learning–based 4D‐synthetic CTs from sparse‐view CBCTs for dose calculations in adaptive proton therapy A Thummerer, C Seller Oria, P Zaffino, S Visser, A Meijers, ... Medical physics 49 (11), 6824-6839, 2022 | 23 | 2022 |
| Inclusion of incidental radiation dose to the cardiac atria and ventricles does not improve the prediction of radiation pneumonitis in advanced-stage non-small cell lung cancer … R Wijsman, FJWM Dankers, EGC Troost, AL Hoffmann, ... International Journal of Radiation Oncology* Biology* Physics 99 (2), 434-441, 2017 | 23 | 2017 |
| Deep learning model for automatic contouring of cardiovascular substructures on radiotherapy planning CT images: Dosimetric validation and reader study based clinical … MG Fernandes, J Bussink, B Stam, R Wijsman, DAX Schinagl, ... Radiotherapy and Oncology 165, 52-59, 2021 | 21 | 2021 |
| Investigation of inter‐fraction target motion variations in the context of pencil beam scanned proton therapy in non‐small cell lung cancer patients LA den Otter, RM Anakotta, M Weessies, CTG Roos, NM Sijtsema, ... Medical Physics 47 (9), 3835-3844, 2020 | 20 | 2020 |
| Survival prediction for stage I-IIIA non-small cell lung cancer using deep learning S Zheng, J Guo, JA Langendijk, S Both, RNJ Veldhuis, M Oudkerk, ... Radiotherapy and oncology 180, 109483, 2023 | 16 | 2023 |
| Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer HP van der Laan, RM Anakotta, EW Korevaar, M Dieters, JF Ubbels, ... Acta Oncologica 58 (12), 1775-1782, 2019 | 15 | 2019 |
| Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter? LEL Hendriks, AJWM Brouns, M Amini, W Uyterlinde, R Wijsman, ... Lung Cancer 101, 68-75, 2016 | 15 | 2016 |
| External validation of an NTCP model for acute esophageal toxicity in locally advanced NSCLC patients treated with intensity-modulated (chemo-) radiotherapy FJWM Dankers, R Wijsman, EGC Troost, CJA Tissing-Tan, MH Kwint, ... Radiotherapy and Oncology 129 (2), 249-256, 2018 | 14 | 2018 |
| Esophageal wall dose-surface maps do not improve the predictive performance of a multivariable NTCP model for acute esophageal toxicity in advanced stage NSCLC patients treated … F Dankers, R Wijsman, EGC Troost, R Monshouwer, J Bussink, ... Physics in Medicine & Biology 62 (9), 3668, 2017 | 12 | 2017 |
| Inter-and intrafractional 4D dose accumulation for evaluating ΔNTCP robustness in lung cancer A Smolders, AC Hengeveld, S Both, R Wijsman, JA Langendijk, ... Radiotherapy and Oncology 182, 109488, 2023 | 11 | 2023 |
| Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands J Evers, LEL Hendriks, K De Jaeger, R Wijsman, D De Ruysscher, ... Lung Cancer 162, 61-70, 2021 | 11 | 2021 |
| Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy F Cortiula, LEL Hendriks, R Wijsman, R Houben, M Steens, S Debakker, ... Radiotherapy and Oncology 190, 110019, 2024 | 8 | 2024 |
